Filing Details
- Accession Number:
- 0001127602-11-012908
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-13 10:14:56
- Reporting Period:
- 2011-04-11
- Filing Date:
- 2011-04-13
- Accepted Time:
- 2011-04-13 10:14:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1498428 | John Cox | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Evp Pharmaceutical Oper & Tech | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-04-11 | 6,900 | $47.92 | 17,253 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-04-11 | 6,900 | $78.00 | 10,353 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-04-11 | 6,900 | $0.00 | 6,900 | $47.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-03-13 | No | 4 | M | Direct |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Includes 534.9884 shares acquired under the Biogen Idec Inc. employee stock purchase plan on 3/31/2011.
- The stock options became exercisable in four (4) equal annual installments commencing one year after the grant date of 3/13/2006.
Billionaire Hedge Funds
